🇺🇸 Bimatoprost .03% sterile ophthalmic solution in United States

Bimatoprost .03% sterile ophthalmic solution (Bimatoprost .03% sterile ophthalmic solution) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Bimatoprost .03% sterile ophthalmic solution in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Bimatoprost .03% sterile ophthalmic solution approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Bimatoprost .03% sterile ophthalmic solution in United States?

Federal University of São Paulo is the originator. The local marketing authorisation holder may differ — check the official source linked above.